Novartis has tapped up an AI-enabled British biotech for a
Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech
- Advertisement -
APLICATIONS
A very human vision for going all-in on AI
It's easy to think about AI as a sort of existential battle between human and machine. Maybe it will be, someday, in a Skynet...
